2022 年
1.Tago T, Shimoda M, Imazato R, Udou R, Katsumata K, Tsuchida A,Suzuki S.
Possibility for avoidance of urgent nighttime operations for acute appendicitis
in a regional core university hospital.
Asian J Endosc Surg. 2022 Jan;15(1):22-28. doi: 10.1111/ases.12953. Epub2021 May 18.（後期研究機関論文）
2.Shimoda M, Kuboyama Y, Suzuki S.
Laparoscopic bailout surgery effective procedure for patients with difficult
laparoscopic cholecystectomy.
Updates Surg. 2022 Oct;74(5):1611-1616. doi: 10.1007/s13304-022-01266-w.
Epub 2022 Mar 10.
3. Shimoda M, Orimoto N, Kuboyama Y, Suzuki S.
Interval Appendectomy Reduces Postoperative Hospital Stay in Patients
With Uncomplicated Appendicitis
Surg.Gastroenterol.Oncal.2022;27(3)217-222

2021 年
1.Suzuki S, Shimoda M, Shimazaki J, Oshiro Y, Nishida K, Shiihara M,
Izumo W, Yamamoto M.
Drain Lipase Levels and Decreased Rate of Drain Amylase Levels as
Independent Predictors of Pancreatic Fistula with Nomogram After
Pancreaticoduodenectomy.
World J Surg. 2021 Jun;45(6):1921-1928.
2.Shimoda M, Udo R, Imasato R, Oshiro Y, Suzuki S.
What are the risk factors of conversion from total cholecystectomy to bailout
surgery?
Surg Endosc. 2021 May;35(5):2206-2210

3.Tago T, Shimoda M, Imazato R, Udou R, Katsumata K, Tsuchida A,Suzuki S.
Possibility for avoidance of urgent nighttime operations for acute appendicitis
in a regional core university hospital.
Asian J Endosc Surg. 2021 May 18 in press（後期研究機関論文）
4.Oshiro Y, Harada H, Hasegawa K, Akutsu N, Yoshizumi T, Kawagishi N,Nanmoku K, Ichimaru N, Okamura K, Ohira M, Itabashi Y, Fujiyama N, Ide K,Okajima H, Ogawa K, Takagi K, Eguchi H, Shinoda M, Nishida K, ShimazakiJ, Shimoda M, Takahashi M, Okamoto H, Suzuki S.
Loss of antibodies to hepatitis E virus in organ transplant patients withhepatitis E.
Hepatol Res. 2021 May;51(5):538-547.
5. Maruyama T, Shimoda M, Sako A, Ueda K, Hakoda H, Sakata A, Suzuki S.
Predictive Effectiveness of the Glasgow Prognostic Score for Gastrointestinal
Stromal Tumors.
Nutr Cancer. 2021;73(8):1333-1339.
6. Maruyama T, Shimoda M, Hakoda H, Sako A, Ueda K, Suzuki S.
Preoperative prognostic nutritional index predicts risk of recurrence after
curative resection for stage IIA colon cancer.
Am J Surg. 2021 Jul;222(1):179-185.
7. Suzuki S, Shimoda M, Shimazaki J, Oshiro Y, Nishda K, Orimoto N,Nagakawa Y, Tsuchida A.
Carbohydrate Antigen 19-9 Is an Invasive Malignancy Preoperative
Prognostic Factor for Intraductal Papillary Mucinous Neoplasms.
Eur Surg Res. 2021;62(4):262-270.
8. Suzuki S, Shimoda M, Shimazaki J, Oshiro Y, Nishda K, Orimoto N,Shihara M,Izumo W,Yamamoto M
Assessment of Preoperative Clinicophysiologic Findings as Risk Factors for
Postoperative Pancreatic Fistula After Pancreaticoduodenectomy
Int Surg 2021 ;105:760-765

2020 年
1.Miyoshi K, Shimoda M, Udo R, Oshiro Y, Suzuki S.
Urinary titin N-terminal fragment concentration is an indicator of preoperative
sarcopenia and nutritional status in patients with gastrointestinal tract andhepatobiliary pancreatic malignancies.
Nutrition. 2020 Nov-Dec;79-80:110957 in press（後期研究期間論文）
2.Suzuki S, Kondo H, Furukawa A, Kawai K, Yukaya T, Shimazui T, Tani M,Yamamoto M.
Prognostic Factors of Preoperative Examinations for Non-occlusive
Mesenteric Ischemia: A Multicenter Retrospective Project Study Conductedby the Japanese Society for Abdominal Emergency Medicine.
World J Surg. 2020 Nov;44(11):3687-3694.
3.Maruyama T, Shimoda M, Hakoda H, Sako A, Ueda K, Suzuki S.
Preoperative prognostic nutritional index predicts risk of recurrence after
curative resection for stage IIA colon cancer.
Am J Surg. 2020 Oct 29: S0002-9610(20)30672-3.
4.Tago T, Suzuki S, Kuroda J, Udou R, Nishida K, Oshiro Y, Shimazaki J,Kou K, Morishita Y, Shimoda M.
Leiomyosarcoma of the transverse colon with lymph node metastasis andmalignant transformation: a case report.
Surg Case Rep. 2020 Oct 2;6(1):256（後期研修期間論文）
5.Maruyama T, Sako A, Ueda K, Suzuki S.
A case of esophageal cancer complicated with methotrexate-related
lymphoproliferative disorder.
Clin J Gastroenterol. 2020 Aug;13(4):483-487.
6.Maruyama T, Shimoda M, Sako A, Ueda K, Hakoda H, Sakata A, Suzuki S.
Predictive Effectiveness of the Glasgow Prognostic Score for Gastrointestinal
Stromal Tumors.
Nutr Cancer. 2020 Aug 4:1-7.

7.Oshiro Y, Nishida K, Shimazaki J, Shimoda M, Suzuki S.
Investigation of morphological and functional changes in the liver andpancreas during bevacizumab treatment.
Scand J Gastroenterol. 2020 Jun;55(6):712-717

2019 年
1.Shimoda M, Hariyama M, Oshiro Y, Suzuki S.
Development of new software enabling automatic identification of the optimal
anatomical liver resectable region, incorporating preoperative liver function.
Oncol Lett. 2019 Dec;18(6):6639-6647.
2.Suzuki S, Shimoda M, Shimazaki J, Maruyama T, Nishida K.
Clinical Outcome of Resected Remnant Pancreatic Cancer After Resection of
the Primary Pancreatic Cancer.
J Invest Surg. 2019 Nov;32(7):670-678.
3.Suzuki S, Shimoda M, Shimazaki J, Maruyama T, Nishida K.
Clinical Outcome of Resected Remnant Pancreatic Cancer After Resection of
the Primary Pancreatic Cancer.
J Invest Surg. 2019 Nov;32(7):670-678.
4.Nagakawa Y, Sahara Y, Hosokawa Y, Murakami Y, Yamaue H, Satoi S, Unno
M, Isaji S, Endo I, Sho M, Fujii T, Takishita C, Hijikata Y, Suzuki S, Kawachi
S, Katsumata K, Ohta T, Nagakawa T, Tsuchida A.
Clinical Impact of Neoadjuvant Chemotherapy and Chemoradiotherapy inBorderline Resectable Pancreatic Cancer: Analysis of 884 Patients at
Facilities Specializing in Pancreatic Surgery.
Ann Surg Oncol. 2019 Jun;26(6):1629-1636.
5.Suzuki S, Shimoda M, Shimazaki J, Maruyama T, Oshiro Y, Nishida K,
Kuroda J, Miyoshi K, Koike N, Harada N.
Number of positive lymph nodes and lymphatic invasion are significant
prognostic factors after pancreaticoduodenectomy for distal
cholangiocarcinoma.
Clin Exp Gastroenterol. 2019 Jun 6;12:255-262.

6.Inoue KI, Kishimoto S, Akimoto K, Sakuma M, Toyoda S, Inoue T, Yoshida KI,Shimoda M, Suzuki S.
Cancer-associated fibroblasts show heterogeneous gene expression andinduce vascular endothelial growth factor A (VEGFA) in response toenvironmental stimuli.
Ann Gastroenterol Surg. 2019 Apr 9;3(4):416-425.
7.Shimoda M, Maruyama T, Nishida K, Suzuki K, Tago T, Shimazaki J,Suzuki S.
Preoperative high C-reactive protein level is associated with an increased
likelihood for conversion from laparoscopic to open appendectomy in patientswith acute appendicitis.
Clin Exp Gastroenterol. 2019 Apr 5;12:141-147.

2018 年
1.Maruyama T, Yoshioka Y, Suzuki S.
Abdominal Aortic Blood Flow Disturbance Due to Binge Eating.
J Gastrointest Surg. 2018 Dec;22(12):2182-2183.
2.Shimoda M, Maruyama T, Nishida K, Suzuki K, Tago T, Shimazaki J,Suzuki S.
Comparison of clinical outcome of laparoscopic versus open appendectomy,single center experience.
Heliyon. 2018 May 24;4(5):e00635.
3.Suzuki S, Shimoda M, Shimazaki J, Maruyama T, Oshiro Y, Nishida K,Sahara Y, Nagakawa Y, Tsuchida A.
Predictive Early Recurrence Factors of Preoperative Clinicophysiological
Findings in Pancreatic Cancer.
Eur Surg Res. 2018;59(5-6):329-338.

4.Shimoda M, Maruyama T, Nishida K, Suzuki K, Tago T, Shimazaki J,Suzuki S
What are preoperative predictors for incidental gallbladder cancer after
routine cholecystectomy?
Journal of Translational Medicine and Research. 2018, 23(1) :51 – 55
5.Shimoda M, Iwasaki Y, Suzuki S
A Protective Effect of Sivelestat From Ischemia/ Reperfusion Injury in a
Porcine Hepatectomy ModelInt Surg. 2018, 103:191 – 198.
6.Shimoda M, Shimizu T, Iwasaki Y, Kato K, Kubota K. What are the risk
factors for non-alcoholic fatty liver disease after pancreatoduodenectomy?
Surgery, Gastroenterology and Oncology. 2018, 23(2): 122 – 129.
7.Shimoda M, Maruyama T, Suzuki K, Tago T, Nishida K, Shimazaki J,Suzuki S
Risk factors for recurrence of hepatocellular carcinoma after curative
resection
Surgery, Gastroenterology and Oncology. 2018, 23: 314 – 319.
8.Yaya Watanabe, Masanori Hariyama, Mitsugi Shimoda.
A System for Estimating Optimal Resected Liver Regions Considering
Practical Surgical Constraints",
ISPACS 2018, pp.415-420

2017 年
1.Suzuki S, Kajiyama H, Takemura A, Shimazaki J, Nishida K, Shimoda M.
The Clinical Outcomes after Total Pancreatectomy.
Dig Surg. 2017;34(2):142-150.
2.Suzuki S, Kajiyama H, Shimoda M, Shimazaki J, Koike N, Harada N.
Prognostic Factors Associated with Preoperative Clinicophysiological
Outcomes of Distal Cholangiocarcinoma.
Dig Surg. 2017;34(6):476-482.

3.Shimoda M, Tago K, Kato M, Aoki T, Kubota K.
Prognostic Factors after Curative Resection for Single-Lesion Hepatocellular
Carcinoma in Patients with Normal Liver Function: A Historical Cohort Study.
Dig Surg. 2017;34(4):281-288.
4.Ishizuka M, Shibuya N, Shimoda M, Kato M, Aoki T, Kubota K
Preoperative hypoalbuminemia is an independent risk factor for conversion
from laparoscopic to open cholecystectomy in patients withcholecystolithiasis.
Asian journal of endoscopic surgery.2017 9(4) :275 – 280.